IL326513A - אוליגונוקליאוטידים משונים הכוללים אוליגונוקליאוטידים מרובים - Google Patents

אוליגונוקליאוטידים משונים הכוללים אוליגונוקליאוטידים מרובים

Info

Publication number
IL326513A
IL326513A IL326513A IL32651326A IL326513A IL 326513 A IL326513 A IL 326513A IL 326513 A IL326513 A IL 326513A IL 32651326 A IL32651326 A IL 32651326A IL 326513 A IL326513 A IL 326513A
Authority
IL
Israel
Prior art keywords
oligonucleotides
containing multiple
modified
modified oligonucleotides
oligonucleotides containing
Prior art date
Application number
IL326513A
Other languages
English (en)
Inventor
Zhen Li
Rui Zhu
Chandramouli Chiruta
Bo Cheng
Original Assignee
Adarx Pharmaceuticals Inc
Zhen Li
Rui Zhu
Chandramouli Chiruta
Bo Cheng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adarx Pharmaceuticals Inc, Zhen Li, Rui Zhu, Chandramouli Chiruta, Bo Cheng filed Critical Adarx Pharmaceuticals Inc
Publication of IL326513A publication Critical patent/IL326513A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/317—Chemical structure of the backbone with an inverted bond, e.g. a cap structure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
IL326513A 2023-08-17 2024-08-16 אוליגונוקליאוטידים משונים הכוללים אוליגונוקליאוטידים מרובים IL326513A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363520092P 2023-08-17 2023-08-17
PCT/US2024/042783 WO2025038970A1 (en) 2023-08-17 2024-08-16 Modified oligonucleotides containing multiple oligonucleotides

Publications (1)

Publication Number Publication Date
IL326513A true IL326513A (he) 2026-04-01

Family

ID=94632737

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326513A IL326513A (he) 2023-08-17 2024-08-16 אוליגונוקליאוטידים משונים הכוללים אוליגונוקליאוטידים מרובים

Country Status (3)

Country Link
AU (1) AU2024325594A1 (he)
IL (1) IL326513A (he)
WO (1) WO2025038970A1 (he)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2342616A2 (en) * 2008-09-23 2011-07-13 Alnylam Pharmaceuticals Inc. Chemical modifications of monomers and oligonucleotides with cycloaddition
EP3919619A1 (en) * 2015-07-17 2021-12-08 Alnylam Pharmaceuticals, Inc. Multi-targeted single entity conjugates
CA3006599A1 (en) * 2016-01-05 2017-07-13 Ionis Pharmaceuticals, Inc. Methods for reducing lrrk2 expression

Also Published As

Publication number Publication date
WO2025038970A1 (en) 2025-02-20
AU2024325594A1 (en) 2026-02-26

Similar Documents

Publication Publication Date Title
GB201904709D0 (en) Chemically modified oligonucleotides
IL284972A (he) אנטיסנס אוליגונוקלאוטידים לעריכת חומצות גרעין
IL315749A (he) אוליגונוקליאוטידים שעברו שינוי
IL309445A (he) אוליגונוקלאוטידים אנטיסנס pikfyve
GB202020310D0 (en) Sars-cov-2 antobodies
IL304751A (he) תהליך לדה-טריטילציה של אוליגונוקליאוטידים
GB202010929D0 (en) Partitions
IL289440A (he) תהליך להסרת הגנה של אוליגונוקליאוטידים
IL326513A (he) אוליגונוקליאוטידים משונים הכוללים אוליגונוקליאוטידים מרובים
EP4320237A4 (en) OLIGONUCLEOTIDES
KR102301882B9 (ko) 살균 장치
EP4428236A4 (en) ANTISENSE OLIGONUCLEOTIDES
GB202305535D0 (en) Oligonucleotide decoy
GB202117092D0 (en) Oligonucleotides
GB202001131D0 (en) Number Allocation
GB202301892D0 (en) Partitions
GB202201798D0 (en) Modified antisense oligonucleotides
CA3294361A1 (en) Modified unc13a oligonucleotides
CA3273921A1 (en) Modified oligonucleotides
HK40129374A (en) Modified oligonucleotides
CA3270109A1 (en) Modified oligonucleotides
AU2023901499A0 (en) Modified oligonucleotides
HK40119903A (en) Modified oligonucleotides
AU2022902992A0 (en) Modified oligonucleotides
HK40105309A (en) Oligonucleotides